Primary Open-angle Glaucoma: Clinical Trials

3 trials for Primary Open-angle Glaucoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 22Completed 2

Follow Primary Open-angle Glaucoma: new trials by email Literature Review of Primary Open-angle Glaucoma trials Research Report on Primary Open-angle Glaucoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intravitreal Mesenchymal Stem Cell Transplantation in Advanced Glaucoma.
Intravitreal transplantation of mesenchymal stem cell, Culture and isolation of autologous bone-marrow mesenchymal stem cells - Retinal Degeneration, Primary Open-angle Glaucoma
Phase 1CompletedUniversity of Sao Paulo22014-01-012019-07-08
Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
LX7101 (0.125%), LX7101 (0.25%), LX7101 Vehicle - Primary Open-angle Glaucoma, Ocular Hypertension
Phase 1 / Phase 2CompletedLexicon Pharmaceuticals632012-03-012015-09-14
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
OPA-6566, Placebo, Latanoprost - Primary Open-angle Glaucoma, Ocular Hypertension
Phase 1 / Phase 2CompletedKubota Vision Inc.1602011-09-012014-03-11

Narrower conditions

Glaucoma, Open-Angle (3)  ·  Ocular Hypertension (2)  ·  Glaucoma (1)  ·  Retinal Degeneration (1)

Broader conditions

Eye Diseases (3)  ·  Glaucoma (2)  ·  Eye Diseases, Hereditary (1)  ·  Ocular Hypertension (1)  ·  Retinal Diseases (1)

Interventions

Culture Techniques (1)  ·  LX-7101 (1)  ·  Latanoprost (1)

Sponsors

Kubota Vision Inc. (1)  ·  Lexicon Pharmaceuticals (1)  ·  University of Sao Paulo (1)

Countries

United States (2)  ·  Brazil (1)

Top investigators

Jayter S Paula, MD (1)  ·  Joel Freiman, M.D., MPH (1)  ·  John W Chandler, MD (1)

Results publications

PMID 33469852